# PLP2

## Overview
PLP2, or proteolipid protein 2, is a gene that encodes a small transmembrane lipoprotein involved in various cellular processes. The protein, also referred to as PLP2, is characterized by its four transmembrane domains, which facilitate its function as an ion channel within the endoplasmic reticulum (ER) (Maia2022PLP2derived). It plays a critical role in protein folding and trafficking, interacting with proteins such as Bap31 and the cytosolic chaperonin complex (CCT) (Feng2019Reduced; Stirling2007Functional). PLP2 is implicated in the immune evasion strategies of viruses, such as Kaposi's sarcoma-associated herpesvirus (KSHV), by aiding in the export of viral E3 ubiquitin ligases from the ER (Timms2013Haploid). Additionally, PLP2 is associated with various pathologies, including cancer and X-linked mental retardation, highlighting its significance in both normal cellular function and disease states (Chen2018Proteolipid; Zhang2007X).

## Structure
Proteolipid protein 2 (PLP2) is a small transmembrane lipoprotein consisting of 152 amino acids. It is characterized by four transmembrane domains, which contribute to its function as an ion channel (Maia2022PLP2derived). The protein is enriched in the colonic epithelium and is localized to the endoplasmic reticulum, where it interacts with Bap31 (Feng2019Reduced; Maia2022PLP2derived). The hydropath profile of PLP2 is similar to a subunit of the H+ vacuolar ATPase, indicating its role in ion transport (Maia2022PLP2derived).

PLP2's structure allows it to multimerize, forming ion channels that are integral to its function (Feng2019Reduced). The protein's involvement in various cellular processes is also linked to its ability to interact with other proteins, such as PI3K, which activates the Akt pathway, a key player in cell proliferation and metastasis (Sonoda2009Proteolipid).

Post-translational modifications and splice variant isoforms of PLP2 have not been detailed in the provided context, and thus cannot be described here. The protein's structural features are crucial for its role in cellular processes and its implications in diseases such as cancer.

## Function
PLP2 (proteolipid protein 2) is involved in several critical cellular processes, primarily within the endoplasmic reticulum (ER). It plays a significant role in the export of viral E3 ubiquitin ligases, such as K3 and K5, from the ER, which is essential for the ubiquitination and downregulation of plasma membrane proteins. This function is crucial for the immune evasion strategies of viruses like Kaposi's sarcoma-associated herpesvirus (KSHV) (Timms2013Haploid).

PLP2 is also implicated in protein folding processes through its interaction with the cytosolic chaperonin complex (CCT). This interaction is essential for the proper folding of cytoskeletal proteins, such as actin and tubulin, which are vital for maintaining cytoskeletal integrity and cell cycle progression (Stirling2007Functional). The protein's role in these processes is underscored by its necessity for cell viability, as demonstrated in yeast models where the absence of PLP2 leads to cell death (Stirling2007Functional).

In addition to its role in protein folding and trafficking, PLP2 is expressed in various human tissues, including the brain, where it may influence cognitive functions. A promoter variant affecting PLP2 expression has been associated with X-linked mental retardation, suggesting its involvement in neuronal development and function (Zhang2007X).

## Clinical Significance
Alterations in the expression of the PLP2 gene have been implicated in various cancers, including gliomas and melanoma. In gliomas, PLP2 is overexpressed, correlating with higher tumor grades and poorer prognosis. This overexpression is associated with aggressive tumor behavior, as it enhances cell proliferation, migration, and invasion. PLP2 overexpression in gliomas is linked to the dysregulation of cell cycle checkpoints and the activation of signaling pathways such as Raf/MEK/ERK, contributing to tumor progression (Chen2018Proteolipid).

In melanoma, PLP2 is involved in metastasis by enhancing cell proliferation, adhesion, and invasion. It activates the PI3K/Akt signaling pathway and increases the secretion of matrix metalloproteinase-2 (MMP-2), which is crucial for extracellular matrix degradation and tumor invasion (Sonoda2009Proteolipid).

PLP2 is also associated with X-linked mental retardation (XLMR). A promoter variant, 311C>A, reduces PLP2 expression by disrupting the binding site for the transcription factor ELK1, which is involved in neuronal development. This variant is more frequent in males with XLMR, suggesting a role in cognitive impairment (Zhang2007X).

In Holstein cattle, a missense variant in PLP2 is linked to congenital mast cell tumors, suggesting a potential X-linked recessive inheritance pattern (Jacinto2022A).

## Interactions
PLP2 (proteolipid protein 2) is involved in several interactions with other proteins, playing a crucial role in various cellular processes. It is known to interact with the viral E3 ubiquitin ligases K3 and K5, encoded by Kaposi's sarcoma-associated herpesvirus (KSHV). These interactions are essential for the downregulation of plasma membrane proteins, as PLP2 facilitates the export of K3 and K5 from the endoplasmic reticulum (ER), enabling them to ubiquitinate and degrade their substrates (Timms2013Haploid). PLP2 also interacts with the ER-resident protein Bap31, which is involved in protein degradation and export from the ER. This interaction suggests that PLP2 may assist in extracting viral ligases from Bap31 for export or serve as a recruitment factor for packaging into ER exit sites (Timms2013Haploid).

In the context of viral immune evasion, PLP2 is hijacked by K3 and K5 to facilitate their function, highlighting its role as a critical host factor for KSHV pathogenesis (Timms2013Haploid). These interactions underscore the importance of PLP2 in the trafficking and function of viral proteins, contributing to the virus's ability to evade the host immune response.


## References


[1. (Zhang2007X) Lilei Zhang, Chunfa Jie, Cassandra Obie, Fatima Abidi, Charles E. Schwartz, Roger E. Stevenson, David Valle, and Tao Wang. X chromosome cdna microarray screening identifies a functional plp2 promoter polymorphism enriched in patients with x-linked mental retardation. Genome Research, 17(5):641–648, April 2007. URL: http://dx.doi.org/10.1101/gr.5336307, doi:10.1101/gr.5336307. This article has 16 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1101/gr.5336307)

[2. (Maia2022PLP2derived) Vera S. C. Maia, Rodrigo Berzaghi, Denise C. Arruda, Fabrício C. Machado, Leticia L. Loureiro, Pollyana M. S. Melo, Alice S. Morais, Alexandre Budu, and Luiz R. Travassos. Plp2-derived peptide rb4 triggers parp-1-mediated necrotic death in murine melanoma cells. Scientific Reports, February 2022. URL: http://dx.doi.org/10.1038/s41598-022-06429-8, doi:10.1038/s41598-022-06429-8. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-022-06429-8)

[3. (Stirling2007Functional) Peter C. Stirling, Martin Srayko, Karam S. Takhar, Andrei Pozniakovsky, Anthony A. Hyman, and Michel R. Leroux. Functional interaction between phosducin-like protein 2 and cytosolic chaperonin is essential for cytoskeletal protein function and cell cycle progression. Molecular Biology of the Cell, 18(6):2336–2345, June 2007. URL: http://dx.doi.org/10.1091/mbc.E07-01-0069, doi:10.1091/mbc.e07-01-0069. This article has 63 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.E07-01-0069)

[4. (Timms2013Haploid) Richard T. Timms, Lidia M. Duncan, Iva A. Tchasovnikarova, Robin Antrobus, Duncan L. Smith, Gordon Dougan, Michael P. Weekes, and Paul J. Lehner. Haploid genetic screens identify an essential role for plp2 in the downregulation of novel plasma membrane targets by viral e3 ubiquitin ligases. PLoS Pathogens, 9(11):e1003772, November 2013. URL: http://dx.doi.org/10.1371/journal.ppat.1003772, doi:10.1371/journal.ppat.1003772. This article has 36 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.ppat.1003772)

[5. (Jacinto2022A) Joana G. P. Jacinto, Luisa Vera Muscatello, Irene M. Häfliger, Cinzia Benazzi, Marilena Bolcato, Arcangelo Gentile, and Cord Drögemüller. A missense variant in plp2 in holstein cattle with x-linked congenital mast cell tumor. Animals, 12(18):2329, September 2022. URL: http://dx.doi.org/10.3390/ani12182329, doi:10.3390/ani12182329. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ani12182329)

[6. (Chen2018Proteolipid) Yi-Hsuan Chen, Dueng-Yuan Hueng, and Wen-Chiuan Tsai. Proteolipid protein 2 overexpression indicates aggressive tumor behavior and adverse prognosis in human gliomas. International Journal of Molecular Sciences, 19(11):3353, October 2018. URL: http://dx.doi.org/10.3390/ijms19113353, doi:10.3390/ijms19113353. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms19113353)

[7. (Sonoda2009Proteolipid) Sonoda. Proteolipid protein 2 is associated with melanoma metastasis. Oncology Reports, December 2009. URL: http://dx.doi.org/10.3892/or_00000645, doi:10.3892/or_00000645. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or_00000645)

[8. (Feng2019Reduced) Zichao Feng, Wenjing Zhou, Jiwei Wang, Qichao Qi, Mingzhi Han, Yang Kong, Yaotian Hu, Yulin Zhang, Anbin Chen, Bin Huang, Anjing Chen, Di Zhang, Wenjie Li, Qing Zhang, Rolf Bjerkvig, Jian Wang, Frits Thorsen, and Xingang Li. Reduced expression of proteolipid protein 2 increases er stress‐induced apoptosis and autophagy in glioblastoma. Journal of Cellular and Molecular Medicine, 24(5):2847–2856, November 2019. URL: http://dx.doi.org/10.1111/jcmm.14840, doi:10.1111/jcmm.14840. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.14840)